Gillian Jalimnson
Gillian Jalimnson is one of Hemp Gazette's staff writers and has been with us since we kicked off in 2015. Gillian sees massive potential for cannabis in areas of health, energy, building and personal care products and is intrigued by the potential for cannabidiol (CBD) as an alternative to conventional treatments. You can contact Gillian here.
Experts Caution Channel Islands on Medicinal Cannabis Prescribing, Citing US Challenges and Mental Health Links
Study Explores Medical Cannabis for Opioid Reduction in Chronic Pain Patients When Cost Barriers Are Addressed
Preliminary Research Explores Cannabigerol (CBG) as a Potential Modulator for Rheumatoid Arthritis Inflammation
Beyond Dopamine: New Research Uncovers Multisystem Brain Networks in Addiction Mechanisms
Explainable AI Predicts CB1 Receptor Affinity and Potency for Cannabinoids and NPS
Federally Funded Study Links Cannabis Access to Reductions in Non-Fatal Opioid Overdoses
Isle of Man Tynwald Questions Hospital Protocol for Medicinal Cannabis Patients
Exploring the Interplay of Medical Cannabis, the HPA Axis, and Inflammation in Depression Research
Understanding Gen Z's Self-Reported Cannabis Use Patterns: Insights from a Recent Survey
Australian and New Zealand Cannabinoid Medicine Organisations Near Merger Completion

